INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Fear Isn't A Strategy: Rethinking AI In Clinical Trials
As AI restrictions rise, needed oversight is slowing trials. This piece explores how delays hurt patients and how sites and sponsors can modernize without sacrificing regulatory trust.
-
One Program. Many Studies: How Experts Keep It All Aligned.
Compare the differences between project and program management in drug development, and how an integrated CRO ensures oversight and continuity from early development through clinical execution.
-
When Should You Rescue Your Clinical Trial From A Bad RTSM?
Stop settling for tech delays that drain your team. Learn how to evaluate a mid-study transition and implement a rescue plan that restores efficiency and control to your clinical operations.
-
Coordinator Services For High-Volume Research Sites
Remove the administrative burden of travel and reimbursements from your site staff with a service providing takes over direct communication, travel inquiries, and administrative entries
-
The New Reality Of Clinical Trial Payment Workflows7/13/2026
Outdated trial payment processes create costly delays. Explore strategies for centralized financial management, participant reimbursement, and improved study execution.
-
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs2/20/2025
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
Improving Trial Readiness Through Community‑Based Models5/19/2026
This webinar explores how inclusive research can be advanced through community partnership models that improve access, build trust and support stronger enrollment and retention.
-
Rethinking Technology For Patients And Sites In Clinical Trials2/18/2026
The solution to administrative burden in clinical trials is not in adding more tools, but in improved integration that allows software to fade into the background.
-
Rethinking Trial Access Through Trust-Driven Design And Local Collaboration5/19/2026
Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
Avance Clinical offers deep scientific expertise and extensive knowledge across a range of specialized therapeutic indications, consistently achieving global regulatory approvals.
-
Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.
-
Global clinical trials face customs challenges. A synchronized Importer of Record service ensures compliance, streamlines logistics, and helps prevent shipment delays.
-
Rare disease trials demand specialized expertise. Learn how patient- and site-focused strategies can reduce burden, strengthen recruitment and retention, and support trial success.